The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver
By:
Authors
Radek Indra
Department of Biochemistry, Faculty of Science, Charles University, Czech Republic
Sandra Jelínková
Department of Biochemistry, Faculty of Science, Charles University, Czech Republic
Katarína Kollárová
Department of Biochemistry, Faculty of Science, Charles University, Czech Republic
Petra Zahumenská
Department of Biochemistry, Faculty of Science, Charles University, Czech Republic
Josef Dvořák
Department of Biochemistry, Faculty of Science, Charles University, Czech Republic
Šárka Dušková
Centre of Occupational Health, National Institute of Public Health, Czech Republic
Helena Dračínská
Department of Biochemistry, Faculty of Science, Charles University, Czech Republic
Language: English
Page range: 441 - 459
Accepted on: Jun 20, 2024
Published on: Sep 14, 2024
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2024 Radek Indra, Sandra Jelínková, Katarína Kollárová, Petra Zahumenská, Josef Dvořák, Šárka Dušková, Helena Dračínská, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.